Emergent Hid Evidence of Covid Vaccine Problems at Plant, Report Saysnews2022-05-10T21:51:44+00:00May 10th, 2022|The New York Times|
McKinsey Opened a Door in Its Firewall Between Pharma Clients and Regulatorsnews2022-04-13T22:06:06+00:00April 13th, 2022|The New York Times|
F.D.A. Rushed a Drug for Preterm Births. Did It Put Speed Over Science?news2022-03-25T15:15:07+00:00March 25th, 2022|The New York Times|
Senate Panel OKs Califf Nomination for F.D.A. Chiefnews2022-01-14T04:32:55+00:00January 14th, 2022|The New York Times|
Senators Question Califf, the F.D.A. Nominee, on Opioid Crisis and Pandemic Responsenews2021-12-14T23:44:00+00:00December 14th, 2021|The New York Times|
F.D.A. Plans to Authorize Pfizer Boosters for All Adults This Weeknews2021-11-17T01:17:59+00:00November 17th, 2021|The New York Times|
Pfizer Asks F.D.A. to Authorize Covid Pill For High-Risk Unvaccinated Peoplenews2021-11-17T00:40:29+00:00November 17th, 2021|The New York Times|
Biden Chooses Robert Califf to Lead F.D.A., Despite Drug Industry Tiesnews2021-11-12T21:31:34+00:00November 12th, 2021|The New York Times|
Democrats Choosing Less Risky Path on Drug Pricesnews2021-11-06T07:00:07+00:00November 6th, 2021|The New York Times|
